Matches in Nanopublications for { <http://purl.org/np/RAEhbEJ1tdhPqM6gNPScX9vIY1ZtUzOz7woeJNzB3sh3E#assertion> ?p ?o ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion wasAttributedTo 0000-0002-3668-2627 provenance.
- assertion generatedAtTime "2022-10-13T13:56:25.822692" provenance.
- assertion wasQuotedFrom " Favipiravir was approved in Japan in 2014 to treat cases of influenza that were unresponsive to conventional treatment. It has been investigated in other countries to treat novel viruses including Ebola and most recently, COVID-19, which was recently approved in the U.S. for treatment of novel viruses such as Ebola and the Ebola virus. Given its efficacy at targetting several strains of influenza, it has been used in Japan to treat influenza patients." provenance.